AWOL cat takes top prize for most unusual pet insurance claimOctober 30, 2019The votes are in for this year’s Hambone Awards by Nationwide and a curious cat has received top honors.
SPONSORED CONTENTHelping manage the hidden signs of stressOur therapeutic nutrition targets underlying stress in cats with GI or urinary issues — helping provide relief to pets and their humans. + Learn More
FDA approves generic canine anti-anxiety medicationOctober 30, 2019Veterinarians in need of a generic drug for their anxious canine patients are in luck.
Economic state of animal health industry remains strong, for nowOctober 30, 2019The economic state of the veterinary profession has remained strong in recent years, thanks, in part, to the expanding economy.
RUSVM readies for West Indies Veterinary Conference October 29, 2019Veterinary professionals from around the globe are set to converge at Ross University School of Veterinary Medicine (RUSVM) for the 2019 West Indies Veterinary Conference (WIVC).
Study finds owners are humanizing their pets more and moreOctober 28, 2019Thinking about moving to the beach because your dog loves water? You're not alone. A new survey finds a pets-are-people-too mentality is influencing marketing and retail trends.
NYC's Animal Medical Center raises $43 million for renovationsOctober 25, 2019AMC has launched the public phase of Gift of Love, a $70-million capital campaign to raise funds for the facility’s renovation and expansion.
IDEXX CEO resigns following spinal cord injuryOctober 25, 2019Jonathan Ayers, president, CEO, and chair of IDEXX Laboratories, is stepping down after suffering a spinal cord injury.
Cat virus could be linked to feline cancerOctober 25, 2019Australian researchers believe a newly discovered feline virus might be the cause of liver cancer in cats, and that this link could lead to the development of new anti-cancer therapies.
Antech acquires Canadian biotech companyOctober 24, 2019Antech Diagnostics has strengthened its laboratory services in Canada with the purchase of Quebec-based biotechnology company, Biovet.
Stereotactic radiation may offer better outcomes in nine cancersOctober 24, 2019New data suggests a specific advanced radiation treatment protocol is leading to better survival outcomes than other therapy options for at least nine tumor types. That's according to PetCure Oncology, which presented its findings at the recent Veterinary Cancer Society Annual Conference (VCS) in Houston, Tex. The pet cancer care provider says nine of the 11 tumor types it studied showed increased median survival time relative to the current body of peer-reviewed published literature for pets treated with stereotactic radiation/stereotactic radiation therapy (SRS/SRT), an advanced form of radiation therapy used in human medicine. The list of tumor types includes brain, nasal, osteosarcoma (bone tumors), mast cell, and melanoma. "We have now treated more than 3,000 pets on-protocol with radiation therapy, including more than 2,200 with stereotactic radiation," says PetCure's chief medical officer, Neal Mauldin, DVM, DACVIM (internal medicine and oncology), DACVR (radiation oncology). "The good news is that many of them are still alive and thriving, so the data is still maturing. But objective analysis of the preliminary data at this point suggests stereotactic radiation can be considered a standard of care for the treatment of many tumor types, much like it already is in human cancer treatment. This …
